Dermatological Toxicity

download Dermatological Toxicity

of 95

Transcript of Dermatological Toxicity

  • 7/30/2019 Dermatological Toxicity

    1/95

    DERMAL TOXICITY

    11/29/2012 1

  • 7/30/2019 Dermatological Toxicity

    2/95

    DERMAL TOXICITY

    SKIN: STRUCTURE, IMPORTANCE

    DERMAL ABSORPTION OF TOXICANTS

    RESPONSE OF SKIN TO INJURY : CLINICAL

    SIGNS

    MANIFESTATION/ TYPES OF DERMAL TOXICITYand TOXIC AGENTS

    EVALUATION OF CUTANEOUS TOXICITY

    11/29/2012 2

  • 7/30/2019 Dermatological Toxicity

    3/95

    SKIN

    Multilayer , heterogeneous organ, external covering.

    Largest organ.

    10

    20% of total body weight.

    11/29/2012 3

  • 7/30/2019 Dermatological Toxicity

    4/95

    Basic Functions/Physiology of skin

    Thermoregulation

    Preventing insensible water loss

    Metabolic, immunological and neurosensory.

    Protect the body against a variety of

    toxicological insults. (Animals: less protectivecompared to humans)

    Directly contacts environmental, chemical and

    other pollutant exposure

    Exhibit symptoms of dermal toxicity when thethreshold limit is passed.

    11/29/2012 4

  • 7/30/2019 Dermatological Toxicity

    5/95

    Structurally Three

    components:

    Superficial lining ofepithelial cells:

    epidermis

    Subepithelial

    connective tissuestroma and

    vasculature: dermis

    Layer of

    subcutaneous fat ofvarying thickness:

    hypodermis.

    11/29/2012 5

  • 7/30/2019 Dermatological Toxicity

    6/95

    Epidermis (consists ofkerationocytes and non-keratinocytes)

    Most important barrier

    stratum corneum stratum lucidum stratum granulosum stratum spinosum

    stratum basale.

    Approximate cell turnoverand self-replacement timein normal human skin is 28days.( differs widely

    across species) Mechanical or chemical

    injuries can increase themitotic rate of basal cells.

    11/29/2012 6

  • 7/30/2019 Dermatological Toxicity

    7/95

    EPIDERMIS

    In general, rodents and cats have a thin

    epidermis, only 2 3 cell layers thick

    Dogs and horses - thicker epidermis

    Pigs have the thickest

    General thumb rule: More sparsely-haired a species: Thicker

    its epidermis will be, in particular thehorny keratin layer.

    Marine mammals-whales: Exceedinglythick, up to ten cell layers or more

    11/29/2012 7

  • 7/30/2019 Dermatological Toxicity

    8/95

    Cross section

    11/29/2012 8

  • 7/30/2019 Dermatological Toxicity

    9/95

    11/29/2012 9

  • 7/30/2019 Dermatological Toxicity

    10/95

    Stratum basale. single layer of cuboidal or columnar cells resting on basal

    lamina ; viable layer of cells in the epidermis; mitotically

    active, keeping the epidermis replenishedStratum spinosum Layers of irregular polyhedral cells. Cells have numerous tonofilaments and small membrane bound organelles (lamellar granules).

    Stratum granulosum Layers of flattened cells ; irregularly shaped, non-membrane

    bound and electrondense keratohyalin granules. Keratinization and maintaining the barrier functions Lamellar granules contain several types of lipids (ceramides,

    cholesterol, fatty acids) and hydrolytic enzymes includingproteases, acid phosphatases, lipases and glycosidases

    11/29/2012 10

  • 7/30/2019 Dermatological Toxicity

    11/95

    Stratum lucidum : Thin layer , in very thick areas : palmer and plantar

    surfaces.Startum Corneum: Outermost layer of epidermis Several layers of completely keratinized dead cells

    (corneocytes) embedded in an extracellular lipid matrix. Brick and mortar model where keratinized cells, the

    bricks, are embedded in the lipid mortar. The dead keratinized cells-highly water absorbent; keep

    the skin moist and soft. The water holding capacity of epidermis: maintained by

    sebum (natural oil covering the skin) secretion from

    glandular structures of the skin. The mature cells. gradually shed from the surface and

    replaced from beneath

    11/29/2012 11

  • 7/30/2019 Dermatological Toxicity

    12/95

    Stratum Corneum:

    The primary barrier of skin

    Provides up to 1000 times the resistance to

    exogenous compounds as compared to the layers

    beneath it.

    Consists of approximately 40% protein and40%water; the rest is mainly lipid.

    Lipophilic substances, : organic solvents and OPC

    insecticides (e.g., parathion, penetrate readily.

    Disruption : by physical (tape striping) or bychemical means: Adversely affect barrier properties.

    11/29/2012 12

  • 7/30/2019 Dermatological Toxicity

    13/95

    Specialized cells of epidermis :Not involved in barrier

    functions of skin

    Melanocytes: involved in skin ; stimulated by UVlight to produce melanin

    granules.

    Merkel cells

    act as mechanoreceptors for touchLangerhans cells

    play a major role in the skin immune response.

    Other specialized regions of the epidermis:

    Skin appendages (ADNEXA) : Hair, sweat and sebaceousglands, hoof, claw, nail, feathers and horn.

    .

    11/29/2012 13

  • 7/30/2019 Dermatological Toxicity

    14/95

    DERMIS:

    Dense irregular connective tissue with collagen, elastic and

    reticular fibers in a mucopolysaccharides ground substance Fibroblasts, mast cells and macrophages: predominant cells

    High content of collagen and elastin secreted by scattered

    fibroblasts, provide the skin with elastic properties.

    Impregnated within the epidermis and dermis are specializedadnexa : Sweat glands, sebaceous glands, hair follicles and

    erector pili muscles are located

    A layer of adipocytes, accumulation of fat : cushioning action

    Capillaries located in the rete ridges at the dermalepidermaljunction; supply to the bulbs of the hair follicles and the

    secretory cells of the sweat glands.

    11/29/2012 14

  • 7/30/2019 Dermatological Toxicity

    15/95

    DERMAL ABSORPTION OF TOXICANTS By passive diffusion or by active transport.

    For polar toxicants the diffusional resistance of the SC is large

    compared to that presented by the viableepidermis and dermis.

    For lipophilic toxicants the resistance of the SC is smaller.

    Generally, topical absorption A sequence ofevents that include partitioning of the moleculeinto the SC from the applied vehicle phase,diffusion through the SC, partitioning from theSC into the viable epidermis, diffusion

    11/29/2012 15

  • 7/30/2019 Dermatological Toxicity

    16/95

    Penetration pathways:

    1 The intercellular/para-cellular path: Via the tortuous but

    continuous intercellular lipids.2 The transcellular path : The toxicants transfer sequentially

    and repeatedly through the bricks and mortar.

    3 The transappendageal path via hair follicles, sweat pores, etc.

    Most molecules follow the first penetration pathway The absorption of certain compounds can take place via

    transfollicular path or sweat pores, often resulting in skin

    penetration (residing within skin) rather than true absorption

    (systemic exposure).

    11/29/2012 16

  • 7/30/2019 Dermatological Toxicity

    17/95

    11/29/2012 17

  • 7/30/2019 Dermatological Toxicity

    18/95

    Factors affecting the dermal toxicity in animals.

    Species,Breed : Epidermal thickness, epidermal cell size, number

    of cell layers and blood flow patterns can vary between species as

    well as within the species Age and Health status : Young and emaciated animals are more

    prone to dermal intoxication than are adults or healthy animals

    Skin condition (dryness, hairiness or thickness)

    Local environment (weather, humidity, temperature).

    Type/Nature: lipophilicity chemical/drug/plant

    Direct/Indirectexposure/concentration

    The ionization state of the penetrant

    Electrolytes in aqueous solution have poor penetrability, and the

    ionization of a weak electrolyte notably reduces its permeability (e.g.,salicylic acid as opposed to sodiumsalicylate). Ions such as Na , K , Al and

    Br penetrate very slowly

    11/29/2012 18

  • 7/30/2019 Dermatological Toxicity

    19/95

    Skin occlusion with fabric or transdermal patches, creams,

    and ointments: increase epidermal hydration, which can

    increase permeability

    The molecular size of the penetrant: Molecules of smallerweight penetrate more rapidly

    Skin occlusion raises the local temperature, important factor

    that enhances permeability

    Organic solvents-methanol, acetone, hexane, and ether. They produce delipidization of the skin, generating

    interstices that transform the tissue

    Anionic and cationic surfactants (soaps, detergents),: alter

    the lipid pathway by fluidization,delipidization of lipids, andproteins within the keratinocytes-denatured. (anionic

    surfactants than non-ionic surfactants)

    11/29/2012 19

  • 7/30/2019 Dermatological Toxicity

    20/95

    Regional variations in areas of the body : Dependenton differences in the thickness of the stratumcorneum - will affect absorption.

    The rate of penetration is in the following order:

    Scrotal > Forehead > Axilla >Scalp > Back =Abdomen > Palm and plantar.(Highly cornified; 100

    to 400 times thicker than other regions)

    Physical integrity of the horny layer (skin diseases thebarrier function is notably diminished (e.g., psoriaticskin).

    11/29/2012 20

  • 7/30/2019 Dermatological Toxicity

    21/95

    Percutaneous absorption driven by passive diffusiondown a concentration gradient described at steadystate by Ficks law of diffusion

    Flux = [(D PC SA)/H](x)

    where Dis the diffusion coefficientPCis the partition coefficient,SA is the applied surface area,H is membrane thickness (or more precisely theintercellular path length)

    x is the concentration gradient across themembrane

    11/29/2012 21

  • 7/30/2019 Dermatological Toxicity

    22/95

    RESPONSE OF SKIN TO INJURY

    Fundamental Cutaneous Non-neoplasticLesions

    The extent and degree of involvement of eachcomponent will depend on

    The agent itself,

    severity of the exposure. factors such as dose,concentration,pH, length of exposure, numberof exposures, and time between exposures.

    Epidermal lesions

    Dermal

    Adnexal

    11/29/2012 22

  • 7/30/2019 Dermatological Toxicity

    23/95

    EPIDERMAL LESIONS Degree of epidermal damage or destruction. ;

    vary from very focal keratinocyte swelling (intracellular edema or ballooningdegeneration) to extensive epidermalcoagulative necrosis.

    Spongiosis or intercellular edema of thespinous layer: characterized by increasedspace between keratinocyte

    Hydropic or vacuolar degeneration of the

    basal layer Individual or focal cell necrosis, also usually

    in the basal layer.

    11/29/2012 23

  • 7/30/2019 Dermatological Toxicity

    24/95

    EPIDERMAL LESIONS: NECROSIS

    Visualised as: devitalized, hypereosinophilic and

    hyalinized epithelial layers with pyknotic nuclei thatloosely line the dermis.

    Necrotic epithelium : sloughed off, leaving a denuded

    dermal surface exposed to the environment

    When the dermis is not compromised and only the

    epidermis is affected, the lesion is called Erosion.

    When the epidermis is sloughed and the dermis is

    involved, the lesion is called anUlcer.

    11/29/2012 24

  • 7/30/2019 Dermatological Toxicity

    25/95

    Epidermis responds with a series of reactive or progressive

    changes that usually include increased proliferation of cells

    (hyperplasia), and increased cell volume /size(hypertrophy)-

    the Usual pattern of response to chronic or protracted toxicant

    exposure of moderate intensity

    Associated with edema and spongiosis,-as an increased number

    of spinous keratinocytes (acanthosis).

    An increased thickness of the epidermis, and is frequently

    accompanied by an increased production of superficial

    anucleated squames in the stratum corneum

    (hyperkeratosis).

    Occasionally Epidermis responds by a decrease in the size ofcells or number of epidermal layers (epidermal atrophy

    /hypotrophy).

    11/29/2012 25

  • 7/30/2019 Dermatological Toxicity

    26/95

    DERMAL LESIONS

    Diffusion through dermal capillaries of a systemically-

    circulating toxicant; Direct penetration of the toxicantthrough the epidermis to cause direct damage to the dermis.

    Subepidermal mononuclearinflammatory cell infiltrates at the

    dermal epidermal interface (lichenoid pattern), or with

    focal perivascular infiltrates of lymphocytes, histiocytic

    macrophages and mast cells.

    Secondary infection: leading to a suppurative or

    pyogranulomatous reaction if opportunistic bacteria or fungi,

    respectively, colonize the area.

    11/29/2012 26

  • 7/30/2019 Dermatological Toxicity

    27/95

    ADNEXAL LESIONS

    Cutaneous adnexa (appendages) undergo dynamic changes of

    degeneration, proliferation, inflammation and repair.

    Typical destructive and involutional changes (e.g., focal

    necrosis, edema, hypertrophy and hyperplasia)

    Partial or total destruction of the structures or the supporting

    stroma may result in disappearance of the appendages from

    the exposed area, due to replacement by less-functional scartissue.

    Severe injury can cause adnexal atrophy or hypotrophy.

    Conversely, some agents are able to induce hyperplasia of

    sebaceous glands and hair follicles

    11/29/2012 27

  • 7/30/2019 Dermatological Toxicity

    28/95

    HAIR LESIONS: TOXIC ALOPECIA

    Hair follicles in a specific phase of the hair Cycle: Anagen(actively growing) or Telogen (stationary) phase.

    Anagen Toxicity Effect becomes evident within days or weeks of toxic

    exposure

    interference with the rapid mitotic activity at the base ofthe hair follicle (hair bulb)

    Eg: cancer chemotherapeutic agents ( doxorubicin -dog,and antigout agent colchicine

    Telogen toxicity

    slower and occurs over months of exposure.

    Heavy metals Eg: chronic arsenic, mercury, selenium,thallium toxicity (in dogs ,cats): alopecia and ulcerationaffecting high friction areas: paws ; face,ears, ventrum,perineum, and mucocutaneous junctions.

    11/29/2012 28

  • 7/30/2019 Dermatological Toxicity

    29/95

    Mechanism: Interfere with the incorporation of cysteine into

    keratins

    Interfere with energy metabolism of proliferatinghair bulb cells, -premature telogen,shedding ofthe affected hairs.

    Other telogenic compounds: iodine (cranial

    alopecia in horses), propanolol, triparanol, andsome anticoagulants, such as heparin andcoumarin, and oral contraceptives.

    In general, unless there is severe damage to

    the follicle, toxic alopecia is reversible onceexposure ceases or the toxicant ismetabolized and detoxified

    11/29/2012 29

  • 7/30/2019 Dermatological Toxicity

    30/95

    ACNE

    Affliction of the

    pilosebaceous units inthe face, upper chest and

    upper back.

    Blockage of thesebaceous duct leading

    from the gland to the hair

    follicle, resulting in

    retention of sebum andenlargement of the gland.

    11/29/2012 30

  • 7/30/2019 Dermatological Toxicity

    31/95

    ACNE VULGARIS Androgen stimulation at puberty leads to excess sebum

    production and as a result of the high local fatty acidconcentration.

    Excessive cornification of the ductal cells to plug the

    orifice.

    Proliferation of resident bacteria and inflammation

    typically result.

    11/29/2012 31

  • 7/30/2019 Dermatological Toxicity

    32/95

    CHLORACNE

    Occupational dermatosis: Exp. To Halogenated hydrocarbons

    (polyhalogenated naphthalenes, biphenyls, dibenzofurans,and contaminants of herbicides, such as polychlorophenol

    and dichloroaniline),

    characterized by an acneiform lesion, on face and behind

    the ear

    Comedones ( blackheads ) are located in these regions,

    external genitalia, in the axillae, shoulders, chest, back,

    abdomen

    Histologically, comedones: dilations of the infundibular or

    suprafollicular area of the hair follicle, with accumulation of

    keratin and sebaceous gland secretion causing cystic dilation

    of the upper third of the hair follicles.

    11/29/2012 32

  • 7/30/2019 Dermatological Toxicity

    33/95

    PIGMENTARY DISTURBANCES

    LEUKODERMA or VITILIGO (HYPOPIGMENTATION)

    Melanocytes protect the skin from harmful effects ofultraviolet light by producing melanin.

    An autoimmune origin, : Loss of melanocytes

    Acquired condition of generalized pigmentation loss

    has a genetic basis.

    Exposure to phenols, catechols, quinones, and

    related compounds, environmental influences,

    chemicalsHYPERPIGMENTATION: UV Light, hypoadrenalism,

    chemicals-Hg,Pb,Bi, zidovudine, bleomycin

    11/29/2012 33

  • 7/30/2019 Dermatological Toxicity

    34/95

  • 7/30/2019 Dermatological Toxicity

    35/95

    URTICARIA (HIVES)

    Wheal and flare reactions, produced by topical exposure to a

    variety of topical agents, especially biogenic polymers

    released from plants and insects.

    The response occurs within one hour of exposure and

    involves the local release of vasoactive substances including

    histamine.

    Generally disappearing within hours and rarely lasting longerthan a day or two.

    Result from degranulation of cutaneous mast cells by liganded

    IgE, leading to release of histamine and other vasoactive

    substances. Bites,stings, Medications,Chemicals (such as turpentine or crude oil),

    Intestinal parasites. Inhaled or ingested allergens, Food allergies Major

    Causes

    11/29/2012 35

  • 7/30/2019 Dermatological Toxicity

    36/95

  • 7/30/2019 Dermatological Toxicity

    37/95

    Neoplastic Lesions

    Papillomas (Warts):

    Cauliflower-like structures, with

    either a narrow or a broad base,

    consisting of a series of folds

    united by common stalks to the

    underlying skin

    Each of the folds : a centralconnective tissue core covered

    by an epidermis-like epithelium.

    The epithelium: thick, with

    numerous mitoses in the

    germinative layers, a thick,usually fully-keratinized

    (orthokeratotic) horny layer.

    11/29/2012 37

  • 7/30/2019 Dermatological Toxicity

    38/95

    In domestic animals : typically virally-induced, and

    generally do not progress to carcinoma, as can

    happen with chemically-induced papillomas inrodent models.

    Papilloma virus infection can act as a cocarcinogen,

    especially with concomitant solar keratosis.

    Chemically-induced papillomas appear to arise from

    metaplastic or hyperplastic hair follicles, especially

    from the infundibular area.

    Papillomas may regress or continue theirprogression toward carcinomas.

    11/29/2012 38

  • 7/30/2019 Dermatological Toxicity

    39/95

    Wheals / UrticariaSharply circumscribed, flat elevations produced byedema of corium.

    VesiclesCircumscribed elevation s of the epidermis producedby accumulation of fluids, either serum or blood

    Blebs/ bullaeLarger counterparts of vesicles are bleb or bullae

    11/29/2012 39

    Wheals

    Vesicles

    Cyst

  • 7/30/2019 Dermatological Toxicity

    40/95

    Pustules:Simple and very superficial abcesses / natural

    sequence of vesiclesScales:Bran like flakes of imperfectly corn-fed superficiallayer of the epidermis

    11/29/2012

    40

    Pustules

    Scales

  • 7/30/2019 Dermatological Toxicity

    41/95

    11/29/2012 41

  • 7/30/2019 Dermatological Toxicity

    42/95

    Treatment is based on the principles.

    Removal of the source of the poison

    Preventing further exposure

    Delaying further absorption

    Hastening elimination of the absorbed poison Providing supportive therapy

    Use of specific antidotes

    11/29/2012 42

    GENERAL LINE OF TREATMENT FOR DERMAL TOXICITY

  • 7/30/2019 Dermatological Toxicity

    43/95

    REMOVAL OF THE SOURCE OF THE POISON ( DERMAL)

    Washing well with plenty of lukewarm water; Drying thoroughly

    and keeping the animal warm

    Clipping of the hair or wool.

    Epidermal structures (wings, nails, claws, feathers, fur): cleaned

    with the greatest care, attention to areas such as the ears,toes etc.

    The cleaning should be undertaken quickly to avoid licking and to

    limit cutaneous absorption. Soapy water rinsing with copious tepid water; repeating as often

    as necessary and dyring carefully.

    Organic solvents (alcohol, white spirit etc.) or oily substances,

    which may actually increase percutaneous absorption of toxicant.:

    Should never be used

    Avoid Rubbing the area vigorously.

    The eyes should be flushed with water or normal saline

    11/29/2012 43

  • 7/30/2019 Dermatological Toxicity

    44/95

    THERAPY OF CUTANEOUS LESIONS

    TOPICAL/ SYSTEMIC ADMINISTRATIONOF Antibiotics, Antiseptics

    Antiinflammatories

    Antihistaminics Dermatologicals: antipruitics,antiseborrhoeics, keratolytics,demulcents, astringents etc

    11/29/2012 44

  • 7/30/2019 Dermatological Toxicity

    45/95

    THREE main Types of ( dermal ) toxicity to skin:

    Direct damage produced by the toxic agent or

    its metabolitesEg: Allergy, Burns, Irritation (with or without cell

    death) and Genotoxicity

    Immune-mediated Toxic effects : Immune

    mediated syndromes

    Phototoxic and photoallergic effects.-photosensitization: Drugs, chemicals and plants

    11/29/2012 45

  • 7/30/2019 Dermatological Toxicity

    46/95

    DIRECT DAMAGE TO SKIN11/29/2012 46

  • 7/30/2019 Dermatological Toxicity

    47/95

    IMMUNE MEDIATED TOXICITY11/29/2012 47

  • 7/30/2019 Dermatological Toxicity

    48/95

    PHOTO TOXIC EFFECTS

    11/29/2012 48

  • 7/30/2019 Dermatological Toxicity

    49/95

    DIRECT DAMAGE TO SKIN

    Topical: Second most frequent route by which chemicalsenter the body of animals.

    Liquid chemicals are generally absorbed well through

    the skin if they can partition into the SC lipids.

    Chemicals in the forms of solids, gases and vapors areonly absorbed through the skin if they are first dissolved

    in the moist layer at the surface of the skin.

    Major target for gaseous and liquid pollutants.

    Allergic or Irritant/ inflammatory conditions of skin :eczema, atopic dermatitis or acne

    11/29/2012 49

  • 7/30/2019 Dermatological Toxicity

    50/95

    CHEMICAL BURNS

    Direct toxicity : chemical burns produced by accidental

    exposure to strong acids, alkali agents, or oxidizing agents

    ACIDS: Coagulate cellular and intercellular proteins in the

    Epidermis/dermis .

    The coagulated necrotic tissue can form a barrier (eschar)

    that inhibits further penetration and damage by the acidic

    chemical

    ALKALIS: Saponify lipids and denature proteins, Producing

    liquefactive necrosis, allowing for deeper penetration of the

    damaging hydroxyl ions, - Greater extent and duration of

    damage. Greater the degree of tissue destruction, and the greater the

    depth of the injury, => secondary inflammatory reaction,:

    increased likelihood- bacterial or fungal colonization50

  • 7/30/2019 Dermatological Toxicity

    51/95

    11/29/2012 51

  • 7/30/2019 Dermatological Toxicity

    52/95

    11/29/2012 52

  • 7/30/2019 Dermatological Toxicity

    53/95

    Classification of Burns

    1st Degree Burns- injures only the top layer of the skin (epidermis)Common Causes: Sunburns, Scalds burns causedby hot liquids or steam (water, oil)

    Symptoms:- Redness of the skin- Mild pain

    - Dry- Blanching - Wash with cool water for severalminutes

    DO NOT:- Directly apply ice

    - Use toothpaste, ointment or any topical creamsunless prescribed

  • 7/30/2019 Dermatological Toxicity

    54/95

    2nd Degree Burns: Injures the top layer of the skin and down to the lower

    layer of the skin (dermis)

    Common causes: - Skin contact with flame or very hot surfaces

    - High concentration chemicals strong bases and acids (hydrofluoric acid,sodium hydroxide)

    First Aid: Cool the area using wet towel or dipping the burned area in cool

    water - Apply sterile pad or if not available

    - Loosely cover with clean cloth

    DO NOT: - Pierce the blisters; - Remove burnt dead skin

    - Pull away the clothing in contact with the burn

    -Directly apply ice

  • 7/30/2019 Dermatological Toxicity

    55/95

    Third degree burns

    3rd Degree Burns- Injures all layers of the

    skin and causes

    permanent tissuedamage- Destroys nerve endings

    on the skin causingnumbness

    - May extend to themuscles and bones- May require skin

    grafting- Requires IMMEDIATE

    medical treatment

    Common Causes:

  • 7/30/2019 Dermatological Toxicity

    56/95

    3rd Degree BurnsFirst Aid:

    -If clothes are caught onfire STOP, DROP ANDROLL-Remove any tightclothing, jewelleries,- Cool the burn using awet towel- Cover with sterile

    pad/cloth or clean cloth- If hands, legs, feet orhead is burned, elevatethem higher from theheart- Remove clothing in

    contact with the burnedskin-Submerge large burnedareas in cool water

  • 7/30/2019 Dermatological Toxicity

    57/95

    CONTACT DERMATITIS:

    Allergic : ACD

    Irritation : ICD Involve inflammatory processes

    Clinically : Erythema (redness), induration

    (thickening and firmness), scaling (flaking) andvesiculation (blistering) in areas of direct contact

    with the chemical.

    11/29/2012 57

  • 7/30/2019 Dermatological Toxicity

    58/95

    IRRITANT CONTACT DERMATITIS

    An inflammatory process of the skin (dermatitis) that is notmediated by the immune system (non immunological).

    Result of acute or chronic exposure to a large number ofunrelated compounds- acids, alkali agents, organic solvents,keratolytic agents, and oxidizing and reducing agents.

    Chemical concentration is high and the exposure time long

    enough. Most common in horses and dogs, generally involving

    glabrous skin surfaces such as the ventrum and perinealareas, (where a protective hair coat that would otherwiseimpair contact is sparse, epidermis is thinner)

    Direct interaction of the toxic compound with immune systemeffectors without intervention of an antigen antibody reaction

    11/29/2012 58

  • 7/30/2019 Dermatological Toxicity

    59/95

    Three levels of interaction with immunoeffectors

    1. Interaction with mast cells to release histamine,serotonin,

    leukotrienes, and other mediators of inflammation. Eg: polymixin

    B, dimethyl sulfoxide, and biogenic polymers that are released by

    plants-nettles; animals- caterpillars and jellyfish.

    2. Activation of complement in the absence of antibody (i.e., via the

    alternate pathway). Eg: radiocontrast media.

    3. Alteration of arachidonic acid metabolism to increaseprostaglandin synthesis. Eg: aspirin, nonsteroidal anti-inflammatory

    agents, and phorbol esters.

    Keratolysis,Lipid and membrane disruption, Protein denaturation,

    Cytotoxicity

    Pathology: PMN margination, Epidermal necrosis, Dermalinflammation

    11/29/2012 59

  • 7/30/2019 Dermatological Toxicity

    60/95

    11/29/2012 60

  • 7/30/2019 Dermatological Toxicity

    61/95

    CELL-MEDIATED IMMUNOTOXIC REACTIONS:

    IgE-dependent Reactions

    The anaphylactic( Atopic or type I) : mediated by IgE antibodies, .

    Eg: foods, inhaled allergens, or injected therapeutic agents (e.g.,

    penicillin, tetracycline, Vitamin K, and vaccines).

    The cytotoxic hypersensitivity reaction (type II), the basis for some

    autoimmune diseases, not demonstrated in immunotoxicologic

    reactions of the skin.Immunocomplex-mediated Reactions (Type III reaction)

    Arthus reaction -: antigen antibody complex mediated

    hypersensitivity reactions.

    The immunoglobulins : Complement-fixing IgG or IgM.

    Eg: Large variety of antigens, most often drugs such as penicillin,

    aminosalicylic acid, and streptomycin

    - 61

  • 7/30/2019 Dermatological Toxicity

    62/95

    ALLERGIC CONTACT DERMATITIS

    Acute allergic reactions which follow after local or

    systemic administration of toxicants Delayed Skin Hypersensitivity (Type IV hypersensitivity)

    Most common drug-associated immunologic condition in

    man and domestic animals, with dogs, then horses, being

    most often affected.

    Typical signs : pruritus (itchiness) and a papular eruption (red

    bumps).

    The paws and muzzle commonly affected in animals, and

    sometimes, the insides of the ears are affected, in dogs.

    11/29/2012 62

  • 7/30/2019 Dermatological Toxicity

    63/95

    Allergic Contact Dermatitis

    Chronic phase : Thickening of theepidermis: acanthosis, parakeratosis

    (abnormal keratinization withretention of keratinocyte nuclei),hyperkeratosis.

    Dermis: chronic superficialperivascular infiltrate that rangesfrom a small perivascular ring oflymphocytes to massive dermalinfiltration by lymphocytes,eosinophils, and mast cells

    If associated with tissuedestruction: dermal fibroblastic

    proliferation changes: Fibrovascularproliferation or granulation tissue,usually culminate in increasedcollagen content in the papillary andreticular dermis (fibrosis or scarring,)

    11/29/2012 63

  • 7/30/2019 Dermatological Toxicity

    64/95

    Substances that have been documented to produce delayed

    hypersensitivity.(ACD)

    Flea collars, poison ivy/oak/sumac, rubber products,dichromates (in cement), and nickel compounds.

    Therapeutic agents such as ethyl minobenzoate and

    neomycin, various dyes and preservatives.

    Chemicals found in soaps, flea collars, shampoos, wool and

    synthetic fibers, leather, plastic and rubber dishes, grasses

    and pollens

    Insecticides, petrolatum, paint, carpet dyes, and rubber and

    wood preservatives.

    11/29/2012 64

    Diagnosis and Testing Patch testing

  • 7/30/2019 Dermatological Toxicity

    65/95

    Diagnosis and Testing Patch testing

    PATCH TEST:

  • 7/30/2019 Dermatological Toxicity

    66/95

    PATCH TEST:

    To find the allergic cause in skin reactions.

    A range of suspected allergens is prepared in soft white paraffin

    (e.g. vaseline) and placed onto a metal disc or strip (about 1cm indiameter). These are then taped to the patients back.

    The skin is marked appropriately and the patient is asked to keep

    the skin dry.

    The patches are left in place for 48 hours. After this time the discs

    are removed and the skin is examined to see if any red inflamedareas (wheals) have appeared.

    If no reaction is seen, then another 48 hours (without the patch) is

    given before the area is re-examined to see if a delayed reaction

    has occurred.

    Steroid creams need to be stopped for 3-4 weeks before testing as

    they may suppress the test response.

    11/29/2012 66

  • 7/30/2019 Dermatological Toxicity

    67/95

  • 7/30/2019 Dermatological Toxicity

    68/95

  • 7/30/2019 Dermatological Toxicity

    69/95

    ACD

    Identify Allergen

    Prevent furtherexposure

    Topical antibiotic

    ointment Antihistaminics

    Topical and oralcorticosteroids

    Immunosuppressants

    ICD

    Antibiotics Antihistaminics

    Antipruritics

    Demulcents

    11/29/2012 69

    TREATMENT

  • 7/30/2019 Dermatological Toxicity

    70/95

    ERYTHEMA MULTIFORME (EM) AND TOXIC EPIDERMAL NECROLYSIS(TEN)

    Rare immune-mediated diseases

    Linked to the inappropriate activation of cytotoxic (CD8 ) T-cells

    against keratinocyte components in the epidermis.

    Binding of cytotoxic T-cells to the offending keratinocytes results in

    apoptosis : erythema, superficial vesiculation blistering) of the

    epidermis, and lymphocytic migration into the epidermis

    (exocytosis) and along the epidermal-dermal junction (interfacedermatitis) in EM.; Necrosis of large areas ofepidermis in EM

    Excessive production and release of cytokines, such as tumor

    necrosis factor- and interleukin-6: in TEN

    TEN: Due to the large areas of skin affected, its fulminating nature

    and the full thickness necrosis of the epidermis, often life-threatening.

    11/29/2012 70

  • 7/30/2019 Dermatological Toxicity

    71/95

    EM and TEN : Humans,dogs, cats,horses, and monkeys.

    sulfonamides, penicillins, andcephalosporins,

    EM Ivermectin, aurothioglucose,griseofulvin, propylthiouracil

    TEN : Levamisole,D-limonene-based fleadips, Anticonvulsants and NSAIDS

    11/29/2012 71

    PHOTOTOXICITY

  • 7/30/2019 Dermatological Toxicity

    72/95

    PHOTOTOXICITY

    Direct immediate reaction involving interaction of incidentlight of a particular wavelength passing through the skin,

    resulting in either release of free electrons/ enhancedexcitement state for electrons in the photosensitizing

    compound.

    As the electrons return to a less excited state, they release

    energy which can cleave certain molecules to produce free

    radicals. This release of energy, or collision with free electrons themselves,

    often leads to the generation of highly reactive singlet oxygen,

    with the free radicals, especially from unsaturated membrane lipid.

    The free radicals in turn interact with and damage proteins,

    membrane lipids (especially unsaturated ones), and nucleic acids

    via chain reactions - more tissue free radicals, : leading to cell injury

    and death.

    11/29/2012 72

  • 7/30/2019 Dermatological Toxicity

    73/95

    Phototoxicity : (Primary)

    Therapeutic agents- phenothiazine, tetracyclines, sulfonamides,

    chlorpromazine, and nalidixic acid.

    Others- acridine, anthracene, phenanthrenes, linear fluorocoumarins(psoralens). ( used for therapeutic purposes in the treatment of psoriasis

    with UV light).

    by endogenous compounds,:

    Porphyria.- Results from a disturbance in the metabolism ofporphyrins, with accumulation of photoactive byproducts in

    the plasma and tissues. (enzyme abnormalities disrupt the

    biosynthetic pathways) skin lesions : due to absorption of visible light by the porphyrin molecules,

    subsequent generation of free radicals

    Hereditary or Others- related to hepatotoxicity or exposure to agents such

    as polychlorinated compounds (e.g., hexachlorobenzene), lead, or alcohol

    11/29/2012 73

  • 7/30/2019 Dermatological Toxicity

    74/95

  • 7/30/2019 Dermatological Toxicity

    75/95

    PHOTOSENSITIZATION

    Severe dermatitis resulting from a complex reaction induced

    by plant pigments /photodynamic substances exposed toultraviolet (UV) sunlight in the skin of animals that have eaten

    certain plants/photodynamic substances

    Associated with Primary/ Secondary- liver damage.

    Non-pigmented skin : the most severe reaction where thesereactive compounds are directly exposed to UV light, most

    likely secondary to light enhanced photooxidation.

    The amino acids susceptible to oxidation (histidine, tyrosine andtryptophan) once oxidized evoke an intense inflammatory response in the

    blood vessels and surrounding cells resulting in tissue necrosis

    - 75

  • 7/30/2019 Dermatological Toxicity

    76/95

    11/29/2012 76

  • 7/30/2019 Dermatological Toxicity

    77/95

    Mechanism

    In ruminants, the photoactive compound phylloerythin isformed from chlorophyll by anaerobic bacteria in therumen.

    Phylloerythrin is readily absorbed into bloodstream, butalso readily excreted by the liver into the bile.

    Even moderate liver damage, however, especially if the

    biliary system is involved, leads to phylloerythrindeposition in other organs, including the skin.

    Triggers a photosensitization reaction :erythema, edema,exudation, and eventual necrosis of sparsely haired non-

    pigmented light/ sun-exposed areas. Damage and inflammation centered round the biliary

    tract, interfering with excretion of phylloerythrin.

    11/29/2012 77

    Phototoxicity in domestic animals (Horses cattle sheep and pigs )

  • 7/30/2019 Dermatological Toxicity

    78/95

    Phototoxicity in domestic animals (Horses, cattle, sheep, and pigs )

    Photodynamic substances: Plant pigments: pyrrolizidine alkaloids (PAs).

    (Senecio, Crotolaria, Cynoglossum , Lantana)

    Fungal toxins (mycotoxin- sporidesmin); drugs

    Much less common (SECONDARY> Primary)

    Fewer photosensitizing drugs used

    Heavy hair coats and generally more heavily-pigmented skin limits the

    areas of potential damage to sparsely haired, less pigmented regions such

    as conjunctiva, ventrum, perineum, nares, teats, and ear tips. Grazing animals, however, can ingest photosensitizing compounds while

    feeding.

    Plants such as

    Buckwheat ( Fagopyrum ) and St. Johns wort ( Hypericum ) contain photoactive

    red helianthrone pigments, while spring parsley ( Cymopterus ), bishops weed (

    Ammi ) andDutchmansbreeches ( Thamnosma ) contain furocoumarins. ; rape

    (Brassica), alfalfa and alsike clover

    11/29/2012 78

  • 7/30/2019 Dermatological Toxicity

    79/95

    11/29/2012 79

  • 7/30/2019 Dermatological Toxicity

    80/95

    11/29/2012 80

    PHOTOALLERGY

  • 7/30/2019 Dermatological Toxicity

    81/95

    PHOTOALLERGY

    A special form of Delayed hypersensitivity.( Type IV)

    Photoallergen elicits an allergic response by forming a complete

    antigen upon absorbing ultraviolet or visible light. Light appears to modify or convert the hapten to a complete

    antigen, by covalently linking the hapten to cellular proteins in the

    epidermis.

    Unlike photosensitization, where the response is immediate,

    the onset is delayed, generally taking 48 hours to manifest.

    Examples : sulfonamide, phenothiazides, coumarin derivatives,

    glycerylp -aminobenzoic acid, andplant products (e.g., ragweed).

    Light stimulates the chemical either to assume an excited state

    that can bind directly to a carrier protein or to yield a stablephotoproduct that becomes conjugated to a carrier.

    11/29/2012 81

    PHOTOALLERGY

  • 7/30/2019 Dermatological Toxicity

    82/95

    PHOTOALLERGY

    Upon recurrent exposure to an exogenous chemical and light,

    a delayed hypersensitivity (Type IV) reaction ensues, leading

    typically to eczema (erythema, vesiculation and itching). Light sensitivity usually subsides within days but may persist

    for several weeks if the chemical is retained in the epidermis.

    Chemicals causing phototoxicity may also be photoallergenic.

    Phototoxic molds Ergot alkaloids (Claviceps purpurea.) can induce gangrene

    in all species of animals if ingested over a period of several

    days or weeks.

    Serotoxins (trichothecene toxin T-2)

    Fusarium tricinctum is diacetoxyscirpenol. It may causedermalnecrosis and gangrene in cattle fed on moldy corn.

    11/29/2012 82

    CLINICAL SIGNS

  • 7/30/2019 Dermatological Toxicity

    83/95

    CLINICAL SIGNS

    Photophobic immediately when exposed to sunlight and squirm in

    apparent discomfort.

    They scratch or rub lightly pigmented, exposed areas of skin (eg,ears, eyelids, muzzle).

    Typical skin lesions, even in black-coated animals. : Erythema

    develops rapidly and is soon followed by edema. If exposure to light

    stops at this stage, the lesions soon resolve.

    When exposure is prolonged, serum exudation, scab formation, andskin necrosis are marked.

    In cattle: Exposure of the tongue while licking may result in glossitis,

    characterized by ulceration and deep necrosis.

    Hepatogenous photosensitivity: icterus may be present.

    11/29/2012 83

    Di i

  • 7/30/2019 Dermatological Toxicity

    84/95

    Diagnosis

    History and Clinical signs (but are similar to the primary actinic

    effects of sunburn in early or mild cases) .

    Evaluation of serum liver enzymes and liver biopsies may benecessary to confirm the presence of hepatic disease.

    Examination of blood, feces, and urine for porphyrins

    Treatment:

    Mostly palliative measures: shaded fully or, preferably,

    housed;allowed to graze only during darkness. Corticosteroids, given parenterally; demulcenrs in the early stages

    Basic wound management techniques, and fly strike prevention,

    liver protectants

    The prognosis and eventual productivity: depends on the site and

    severity of the primary lesion and/or hepatic disease, and to thedegree of resolution

    11/29/2012 84

    S C C S

  • 7/30/2019 Dermatological Toxicity

    85/95

    SKIN CANCERS

    Skin cancer is the most

    common neoplasm in

    humans, accounting for

    nearly one-third of all

    cancers.

    Sunlight, which damages

    epidermal cell DNA.

    The p53 tumor suppressor

    gene is a major target in

    which damage occurs earlyand is detectable in:

    squamous cell carcinomas.

    11/29/2012 85

    K t th

  • 7/30/2019 Dermatological Toxicity

    86/95

    Keratoacanthomas

    Morphologically very similar

    Appear after exposure to UV radiation or complete carcinogens

    starts as an intradermal growth of epithelial prolongationsoriginating in the hair follicles.

    It usually acquires a cup-shaped architecture, with a central horny

    crater that has a papillomatous exophytic component and an

    endophytic component of deeply-penetrating epithelial cords that

    usually do not invade the subcutaneous tissue.Squamous cell carcinoma and Basal cell carcinomas:

    (common in dogs and cats)

    UV exposure, most commonly : chronic exposure toarsenic and PAHs

    Histologically, squamous cell carcinomas are usually well-differentiated, often with abundant amounts of keratinproduction

    11/29/2012 86

    DERMATOLOGIC TOXICITY OF CHEMOTHERAPEUTIC

    AGENTS

  • 7/30/2019 Dermatological Toxicity

    87/95

    AGENTS

    TOPICAL CHEMICALS CAUSING DERMAL TOXICITY

  • 7/30/2019 Dermatological Toxicity

    88/95

    TOPICAL CHEMICALS CAUSING DERMAL TOXICITY

    PAHs:

    VOCs:

    Pesticides

    Detergents, solvents, corrosives and other household

    preparations

    SYSTEMIC COMPOUNDS CAUSING DERMAL TOXICITY :

    Heavy metals.

    11/29/2012 88

    P l li ti h d b (PAC)

  • 7/30/2019 Dermatological Toxicity

    89/95

    Polycyclic aromatic hydrocarbons (PAC)

    PAHs:Coal tar, Chlorinated PAHs,

    polychlorodibenzodioxines and polychlorofuranes

    Inert chemically, but tend to accumulate in membranes

    and thus perturb cell function if they were not removed.

    Hydroxylated by a number of cytochrome P450isozymes, primarily 1A1 and 1B1 in epidermal cells and

    conjugated for disposal from the body.

    Oxidative biotransformation, produces electrophilicepoxides that can form DNA adducts.

    11/29/2012 89

    VOLATILE ORGANIC COMPOUNDS (VOC)

  • 7/30/2019 Dermatological Toxicity

    90/95

    VOLATILE ORGANIC COMPOUNDS (VOC)

    Hydrocarbons, ketones, aldehydes, solvents

    (benzene, fluorocarbons) and gases (methane) aregenerated from automobiles and industries.

    Highly genotoxic, inducing cancers in various

    tissues.

    Precancerous lesions in the lungs and in the skin

    11/29/2012 90

    PESTICIDES

  • 7/30/2019 Dermatological Toxicity

    91/95

    PESTICIDES 97% of all pesticide exposures are

    dermal.(other : inhalational, oral ocular)

    Common : Hands and forearms(humans).

    Dermatitis : Most common reported symptom

    associated with exposure.

    OPC,OCC,Pyrethroids, Rodenticides,Weedicides

    11/29/2012 91

    H t l

  • 7/30/2019 Dermatological Toxicity

    92/95

    Heavy metals Highly Toxic: Arsenic, lead, cadmium,

    chromium , Ni Moderately toxic : iron,zinc, selenium, Hg,Cu.

    Redistribution of metals

    Act directly or indirectly on intracellular proteinsin the skin

    Chelation

    Interference in energy production, metabolism

    Exposure in drinking water is linked to skin,

    bladder and lung cancer.

    11/29/2012 92

    EVALUATION OF CUTANEOUS TOXICITY

  • 7/30/2019 Dermatological Toxicity

    93/95

    EVALUATION OF CUTANEOUS TOXICITY

    Assessment methods (Invivomodels)

    To assess the dermal uptake of topically applied toxicants

    Cutaneous microdialysis

    Tape stripping

    Skin surface biopsies

    Skin Irritation Tests : Designed to differentiate between

    Agents that produce minor and reversible inflammatory

    changes (minor irritants)

    Those that induce severe inflammation (major irritants)

    Those that cause massive destruction or necrosis of

    cutaneous structures (corrosive agents).

    Draize Technique:

    11/29/2012 93

    DRAIZE technique:

  • 7/30/2019 Dermatological Toxicity

    94/95

    Applying 0.5 g of the test substance under a gauze pad to the skin of rats/

    rabbits or guinea pigs.

    Young adult animals (same sex), rats between 8 and 12 weeks old, rabbits

    at least 12 weeks and guinea pigs between 5 and 6 weeks old at thebeginning of dosing should be used.

    The weight variation of animals used in a test should be within 20 percent of

    the mean weight for each sex.

    Semifluids and liquids can be applied directly; solids should be dissolved

    or moistened with adequate solvents.

    Each animal can be used for four (guinea pig) or six (rabbit) patch tests;

    six animals should be used to test each substance.

    The Draize procedure can be modified to use abraded skin for substances

    that might come in direct contact with the

    dermis.

    The grossly observable skin reaction: at 4, 24, and 72 hours after

    application, and scored according to Draizes scale

    11/29/2012 94

  • 7/30/2019 Dermatological Toxicity

    95/95

    THANK YOU